Suven Life Sciences informs about press release

07 Dec 2015 Evaluate

Suven Life Sciences has informed about a Press Release dated December 07, 2015 titled ‘Suven Initiates Phase 2A trial of SUVN-502 in USA in Alzheimers Disease’.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

166.95 0.10 (0.06%)
01-Jan-2026 10:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.55
Dr. Reddys Lab 1254.70
Cipla 1503.65
Zydus Lifesciences 908.85
Lupin 2084.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×